Table of Contents
For most of medicine’s history, the evidence a clinician needed was scarce, scattered and difficult to retrieve at the point of care. Today, the problem has shifted. Clinicians are practicing in an environment defined by abundance: clinical studies, guidelines, summaries, search results and now, AI-generated answers that appear instantly, sound authoritative and are only a search bar away. That abundance is exactly why clinical AI validation has become the central question facing health systems today.
Why Clinical AI Validation Depends on Discernment, Not Access
“The era has shifted,” said Sheila Bond, MD, Director of Clinical Content Strategy at Wolters Kluwer Health. “Access is no longer the problem. It’s what you do with what you can access.” For Bond, this is the practical challenge of clinical AI: the issue is not whether generative AI can produce fluent answers, but whether those answers are grounded, valid, clinically appropriate and accountable to the standards medicine has spent decades building.
The Skill That Matters Now
The skill that matters now is discernment: knowing which answer to trust when a patient is in front of a clinician. That is why clinical intelligence, the layer that pairs expert, evidence-based knowledge with machine synthesis, is only as trustworthy as the clinical AI validation layer beneath it.
The Risks of Unvalidated AI
Bond is deliberate about the language of trust. “Clinicians should not be asked to trust an AI tool in the same way they might trust a seasoned colleague,” she said. Instead, they should apply the same critical discipline that has long defined evidence-based medicine. “You come to everything with a critical eye, that’s what our field is about,” Bond said. “We teach critical appraisal and evidence-based medicine.“
Two Distinct Risks Without Proper Validation
When an AI tool reaches the point of care without adequate validation, Bond sees two distinct risks. The first is immediate and practical: “I’ve been in medicine for over 20 years, and I’ve seen how words are used. When guidance comes from a source that sounds authoritative, and decisions are rushed, clinicians may act on it exactly as presented.” The second risk is quieter but potentially more consequential, the gradual erosion of the critical appraisal culture that evidence-based medicine depends on, underscoring why clinical AI validation must be built into every layer of deployment.
Why Plausible Isn’t the Same as Valid
“Evidence-based medicine is not one person looking at one study and deciding what it means,” Bond said. “It requires diversity of perspective, depth of knowledge and methodologic rigor to keep us honest.” The danger, she said, is ceding that discipline to a model that can generate an answer that is pleasing, plausible and fluent. But plausible is not the same as valid, and without a critical eye and a validation layer, the difference can become difficult to discern.
Why Benchmarks Alone Fall Short
Much of the public conversation about clinical AI trust has centered on benchmarks: medical exam scores, case challenges, leaderboard performance and other single-point measures. Bond welcomes the scrutiny but cautions against overinterpreting any one metric. “Those single data points don’t encapsulate who will become a good physician, or the totality of what being a good clinician is,” Bond said. “The same goes for AI models.”
A Four-Dimensional Approach to Clinical AI Validation
At Wolters Kluwer, the validation layer behind UpToDate Expert AI is designed around four dimensions. The first is clinical intent, whether the system does what clinicians need and expect it to do, requiring both human expert review and predefined automated measures drawing on more than 7,600 contributors and tens of thousands of criteria.
Knowledge Integrity, Red Teaming, and Continuous Learning
The second dimension is knowledge integrity, ensuring answers are traceable to authoritative content rather than making unsupported leaps from isolated studies. The third is deliberate stress testing for risk and edge cases through red teaming, where teams continuously challenge the system to identify failure modes before they reach users. The fourth is a continuous learning loop, in which clinician feedback is audited and fed back into both the system and the underlying content, reflecting that clinical AI validation is not a one-time event but an ongoing responsibility.
What Leaders Should Ask About Clinical AI Validation
For clinical and health IT leaders evaluating AI tools, Bond emphasizes diligence and accountability: who is responsible for the system, what principles guide its development, and what governance processes oversee it. From there, leaders should examine what sources the tool relies on, how those sources are curated, whether answers can be traced back to trusted content, how often the model uses the intended knowledge base, and what its hallucination rates are.
Understanding Performance Characteristics
“I don’t make diagnostic tests, but I use them and I know their performance characteristics,” Bond said. “It’s the same with AI. You should understand how well your AI works and what makes it trustworthy.” Clinicians cannot be removed from this process, since the people closest to patient care are the ones who know what’s worth measuring in the first place.
How Clinical AI Validation Should Ultimately Be Judged
AI in healthcare should be judged the same way other technologies introduced into patient care are judged: not by how sophisticated its components are, but by whether it supports better decisions, safer care and stronger outcomes for patients. Generative AI can be made to move fast; getting clinical AI validation right for healthcare is both more difficult and more important.
An Epistemic Shift Requiring Extreme Care
Like any technology used in patient care, generative AI should be held to rigorous standards: grounded in trusted sources, transparent about how it produces its outputs, and continuously validated by the clinicians and organizations accountable for its use. “This is an epistemic shift,” Bond said. “It’s going to change how we think and reason. It’s going to change us. So we’ve got to do it with extreme care.”
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
